CN: 32-1845/R
ISSN: 2095-6975
Cite this paper:
0
CAO Si-Yu, YE Sheng-Jie, WANG Wei-Wei, WANG Bing, ZHANG Tong, PU Yi-Qiong. Progress in active compounds effective on ulcerative colitis from Chinese medicines[J]. Chinese Journal of Natural Medicines, 2019, 17(2): 81-102

Progress in active compounds effective on ulcerative colitis from Chinese medicines

CAO Si-Yu1, YE Sheng-Jie1, WANG Wei-Wei1,2, WANG Bing1,2, ZHANG Tong1,2, PU Yi-Qiong2
1 School of Pharmacy, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China;
2 Experiment Center for Teaching and Learning, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China
Abstract:
Ulcerative colitis (UC), a chronic inflammatory disease affecting the colon, has a rising incidence worldwide. The known pathogenesis is multifactorial and involves genetic predisposition, epithelial barrier defects, dysregulated immune responses, and environmental factors. Nowadays, the drugs for UC include 5-aminosalicylic acid, steroids, and immunosuppressants. Long-term use of these drugs, however, may cause several side effects, such as hepatic and renal toxicity, drug resistance and allergic reactions. Moreover, the use of traditional Chinese medicine (TCM) in the treatment of UC shows significantly positive effects, low recurrence rate, few side effects and other obvious advantages. This paper summarizes several kinds of active compounds used in the experimental research of anti-UC effects extracted from TCM, mainly including flavonoids, acids, terpenoids, phenols, alkaloids, quinones, and bile acids from some animal medicines. It is found that the anti-UC activities are mainly focused on targeting inflammation or oxidative stress, which is associated with increasing the levels of anti-inflammatory cytokine (IL-4, IL-10, SOD), suppressing the levels of pro-inflammatory cytokines (TNF-α, IL-1β, IL-6, IL-8, IL-23, NF-κB, NO), reducing the activity of MPO, MDA, IFN-γ, and iNOS. This review may offer valuable reference for UC-related studies on the compounds from natural medicines.
Key words:    Ulcerative colitis    Chinese medicine    Flavonoids    Terpenoids    Alkaloids   
Received: 2018-09-10   Revised:
Tools
PDF (4853 KB) Free
Print this page
Email this article to others
Authors
Articles by CAO Si-Yu
Articles by YE Sheng-Jie
Articles by WANG Wei-Wei
Articles by WANG Bing
Articles by ZHANG Tong
Articles by PU Yi-Qiong
References:
[1] Wan P, Chen H, Guo Y, et al. Advances in treatment of ulcerative colitis with herbs:from bench to bedside[J]. World J Gastroenterol, 2014, 20(39):14099-14104.
[2] Pastorelli L, Pizarro TT, Cominelli F, et al. Emerging drugs for the treatment of ulcerative colitis[J]. Expert Opin Emerg Drugs, 2009, 14(3):505-521.
[3] Zhang C, Jiang M, Lu A. Considerations of traditional Chinese medicine as adjunct therapy in the management of ulcerative colitis[J]. Clin Rev Allergy Immunol, 2013, 44(3):274-283.
[4] Salaga M, Zatorski H, Sobczak M, et al. Chinese herbal medicines in the treatment of IBD and colorectal cancer:a review[J]. Curr Treat Options Oncol, 2014, 15(3):405-420.
[5] Pandurangan AK, Kumar SA, Dharmalingam P, et al. Luteolin, a bioflavonoid inhibits azoxymethane-induced colon carcinogenesis:involvement of iNOS and COX-2[J]. Pharmacogn Mag, 2014, 10(Suppl 2):S306-310.
[6] Karrasch T, Kim JS, Jang BI, et al. The flavonoid luteolin worsens chemical-induced colitis in NF-kappaB (EGFP) transgenic mice through blockade of NF-kappaB-dependent protective molecules[J]. PLos One, 2007, 2(7):e596.
[7] Zhang CL, Zhang S, He WX, et al. Baicalin may alleviate inflammatory infiltration in dextran sodium sulfate-induced chronic ulcerative colitis via inhibiting IL-33 expression[J]. Life Sci, 2017, 186:125-132.
[8] Yu FY, Huang SG, Zhang HY, et al. Effects of baicalin in CD4+ CD29+ T cell subsets of ulcerative colitis patients[J]. World J Gastroenterol, 2014, 20(41):15299-15309.
[9] Dai SX, Zou Y, Feng YL, et al. Baicalin down-regulates the expression of macrophage migration inhibitory factor (MIF) effectively for rats with ulcerative colitis[J]. Phytother Res, 2012, 26(4):498-504.
[10] Goncalves LM, Valente IM, Rodrigues JA. An overview on cardamonin[J]. J Med Food, 2014, 17(6):633-640.
[11] Kim YJ, Ko H, Park JS, et al. Dimethyl cardamonin inhibits lipopolysaccharide-induced inflammatory factors through blocking NF-kappaB p65 activation[J]. Int Immunopharmacol, 2010, 10(9):1127-1134.
[12] Hatziieremia S, Gray AI, Ferro VA, et al. The effects of cardamonin on lipopolysaccharide-induced inflammatory protein production and MAP kinase and NF-kappaB signalling pathways in monocytes/macrophages[J]. Br J Pharmacol, 2006, 149(2):188-198.
[13] Ali AA, Abd Al Haleem EN, Khaleel SA, et al. Protective effect of cardamonin against acetic acid-induced ulcerative colitis in rats[J]. Pharmacol Rep, 2017, 69(2):268-275.
[14] Lee YS, Choi EM. Myricetin inhibits IL-1beta-induced inflammatory mediators in SW982 human synovial sarcoma cells[J]. Int Immunopharmacol, 2010, 10(7):812-814.
[15] Chen W, Li Y, Li J, et al. Myricetin affords protection against peroxynitrite-mediated DNA damage and hydroxyl radical formation[J]. Food Chem Toxicol, 2011, 49(9):2439-2444.
[16] Nirmala P, Ramanathan M. Effect of myricetin on 1, 2 dimethylhydrazine induced rat colon carcinogenesis[J]. J Exp Ther Oncol, 2011, 9(2):101-108.
[17] Kang NJ, Jung SK, Lee KW, et al. Myricetin is a potent chemopreventive phytochemical in skin carcinogenesis[J]. Ann N Y Acad Sci, 2011, 1229:124-132.
[18] Zhao J, Hong T, Dong M, et al. Protective effect of myricetin in dextran sulphate sodium-induced murine ulcerative colitis[J]. Mol Med Rep, 2013, 7(2):565-570.
[19] Zhang Z, Wu X, Cao S, et al. Chlorogenic acid ameliorates experimental colitis by promoting growth of akkermansia in mice[J]. Nutrients, 2017, 9(7):677.
[20] Zatorski H, Salaga M, Zielinska M, et al. Experimental colitis in mice is attenuated by topical administration of chlorogenic acid[J]. Naunyn Schmiedebergs Arch Pharmacol, 2015, 388(6):643-651.
[21] Shin HS, Satsu H, Bae MJ, et al. Catechol groups enable reactive oxygen species scavenging-mediated suppression of PKD-NFkappaB-IL-8 signaling pathway by chlorogenic and caffeic acids in human intestinal cells[J]. Nutrients, 2017, 9(2):165.
[22] Palócz O, Pászti-Gere E, Gálfi P, et al. Chlorogenic acid combined with lactobacillus plantarum 2142 reduced LPS-induced intestinal inflammation and oxidative stress in IPEC-J2 Cells[J]. PLoS One, 2016, 11(11):e0166642.
[23] Pandurangan AK, Mohebali N, Esa NM, et al. Gallic acid suppresses inflammation in dextran sodium sulfate-induced colitis in mice:possible mechanisms[J]. Int Immunopharmacol, 2015, 28(2):1034-1043.
[24] Kim H, Banerjee N, Barnes RC, et al. Mango polyphenolics reduce inflammation in intestinal colitis-involvement of the miR-126/PI3K/AKT/mTOR axis in vitro and in vivo[J]. Mol Carcinog, 2017, 56(1):197-207.
[25] Kim H, Banerjee N, Ivanov I, et al. Comparison of anti-inflammatory mechanisms of mango (Mangifera Indica L.) and pomegranate (Punica Granatum L.) in a preclinical model of colitis[J]. Mol Nutr Food Res, 2016, 60(9):1912-1923.
[26] Xing JF, Sun JN, Sun JY, et al. Protective effects of 3, 4-oxo-isopropylidene-shikimic acid on experimental colitis induced by trinitrobenzenesulfonic acid in rats[J]. Dig Dis Sci, 2012, 57(8):2045-2054.
[27] Xing J, You C, Dong K, et al. Ameliorative effects of 3, 4-oxo-isopropylidene-shikimic acid on experimental colitis and their mechanisms in rats[J]. Int Immunopharmacol, 2013, 15(3):524-531.
[28] Kim SJ, Kim MC, Um JY, et al. The beneficial effect of vanillic acid on ulcerative colitis[J]. Molecules, 2010, 15(10):7208-7217.
[29] Jang SE, Jeong JJ, Hyam SR, et al. Ursolic acid isolated from the seed of Cornus officinalis ameliorates colitis in mice by inhibiting the binding of lipopolysaccharide to Toll-like receptor 4 on macrophages[J]. J Agric Food Chem, 2014, 62(40):9711-9721.
[30] Li Q, Wang X, Yang Z, et al. Menthol induces cell death via the TRPM8 channel in the human bladder cancer cell line T24[J]. Oncology, 2009, 77(6):335-341.
[31] Wang Y, Wang X, Yang Z, et al. Menthol inhibits the proliferation and motility of prostate cancer DU145 cells[J]. Pathol Oncol Res, 2012, 18(4):903-910.
[32] Ghasemi-Pirbaluti M, Motaghi E, Bozorgi H. The effect of menthol on acute experimental colitis in rats[J]. Eur J Pharmacol, 2017, 805:101-107.
[33] Tao Q, Wang B, Zheng Y, et al. Triptolide ameliorates colonic fibrosis in an experimental rat model[J]. Mol Med Rep, 2015, 12(2):1891-1897.
[34] Zhang H, Gong C, Qu L, et al. Therapeutic effects of triptolide via the inhibition of IL-1beta expression in a mouse model of ulcerative colitis[J]. Exp Ther Med, 2016, 12(3):1279-1286.
[35] Zhang H, Chen W. Interleukin 6 inhibition by triptolide prevents inflammation in a mouse model of ulcerative colitis[J]. Exp Ther Med, 2017, 14(3):2271-2276.
[36] Wang Z, Jin H, Xu R, et al. Triptolide downregulates Rac1 and the JAK/STAT3 pathway and inhibits colitis-related colon cancer progression[J]. Exp Mol Med, 2009, 41(10):717-727.
[37] Zhu Q, Zheng P, Chen X, et al. Andrographolide presents therapeutic effect on ulcerative colitis through the inhibition of IL-23/IL-17 axis[J]. Am J Transl Res, 2018, 10(2):465-473.
[38] Zhu Q, Zheng P, Zhou J, et al. Andrographolide affects Th1/Th2/Th17 responses of peripheral blood mononuclear cells from ulcerative colitis patients[J]. Mol Med Rep, 2018, 18(1):622-626.
[39] Yang Y, Yan H, Jing M, et al. Andrographolide derivative AL-1 ameliorates TNBS-induced colitis in mice:involvement of NF-small ka, CyrillicB and PPAR-gamma signaling pathways[J]. Sci Rep, 2016, 6:29716.
[40] Gao Z, Yu C, Liang H, et al. Andrographolide derivative CX-10 ameliorates dextran sulphate sodium-induced ulcerative colitis in mice:Involvement of NF-kappaB and MAPK signalling pathways[J]. Int Immunopharmacol, 2018, 57:82-90.
[41] Niu YT, Zhao YP, Jiao YF, et al. Protective effect of gentiopicroside against dextran sodium sulfate induced colitis in mice[J]. Int Immunopharmacol, 2016, 39:16-22.
[42] Asher GN, Spelman K. Clinical utility of curcumin extract[J]. Altern Ther Health Med, 2013, 19(2):20-22.
[43] Salomon N, Lang A, Gamus D. Curcumin add-on therapy for ulcerative colitis[J]. Harefuah, 2015, 154(1):56-58, 66.
[44] Vecchi Brumatti L, Marcuzzi A, Tricarico PM, et al. Curcumin and inflammatory bowel disease:potential and limits of innovative treatments[J]. Molecules, 2014, 19(12):21127-21153.
[45] Sreedhar R, Arumugam S, Thandavarayan RA, et al. Curcumin as a therapeutic agent in the chemoprevention of inflammatory bowel disease[J]. Drug Discov Today, 2016, 21(5):843-849.
[46] Baliga MS, Joseph N, Venkataranganna MV, et al. Curcumin, an active component of turmeric in the prevention and treatment of ulcerative colitis:preclinical and clinical observations[J]. Food Funct, 2012, 3(11):1109-1117.
[47] Viljakainen HT, Pekkinen M, Saarnio E, et al. Dual effect of adipose tissue on bone health during growth[J]. Bone, 2011, 48(2):212-217.
[48] Deguchi Y, Andoh A, Inatomi O, et al. Curcumin prevents the development of dextran sulfate Sodium (DSS)-induced experimental colitis[J]. Dig Dis Sci, 2007, 52(11):2993-2998.
[49] Wang Y, Tang Q, Duan P, et al. Curcumin as a therapeutic agent for blocking NF-kappaB activation in ulcerative colitis[J]. Immunopharmacol Immunotoxicol, 2018, doi:10.1080/08923973.2018.1469145.
[50] Yang M, Wang J, Yang C, et al. Oral administration of curcumin attenuates visceral hyperalgesia through inhibiting phosphorylation of TRPV1 in rat model of ulcerative colitis[J]. Mol Pain, 2017, 13:1744806917726416.
[51] Xin KB, Zhang JL, Yang J, et al. A Study on the effect of Tanshinone ⅡA sulfonate injection on the clinical efficacy of ulcerative colitis[J]. Prog Modern Biomed, 2015, 15(34):6701-6703, 6623.
[52] Huang G, Ye L, Du G, et al. Effects of curcumin plus Soy oligosaccharides on intestinal flora of rats with ulcerative colitis[J]. Cell Mol Biol (Noisy-le-grand), 2017, 63(7):20-25.
[53] Zhang F, Ma N, Gao YF, et al. Therapeutic effects of 6-gingerol, 8-gingerol, and 10-gingerol on dextran sulfate sodium-nduced acute ulcerative colitis in rats[J]. Phytother Res, 2017, 31(9):1427-1432.
[54] Ajayi BO, Adedara IA, Farombi EO. Pharmacological activity of 6-gingerol in dextran sulphate sodium-induced ulcerative colitis in BALB/c mice[J]. Phytother Res, 2015, 29(4):566-572.
[55] Dugasani S, Pichika MR, Nadarajah VD, et al. Comparative antioxidant and anti-inflammatory effects of 6-gingerol, 8-gingerol, 10-gingerol and 6-shogaol[J]. J Ethnopharmacol, 2010, 127(2):515-520.
[56] Shim S, Kim S, Choi DS, et al. Anti-inflammatory effects of 6-shogaol:potential roles of HDAC inhibition and HSP70 induction[J]. Food Chem Toxicol, 2011, 49(11):2734-2740.
[57] Sun X, Li Q, Gong Y, et al. Low-dose theophylline restores corticosteroid responsiveness in rats with smoke-induced airway inflammation[J]. Can J Physiol Pharmacol, 2012, 90(7):895-902.
[58] Zhang M, Viennois E, Prasad M, et al. Edible ginger-derived nanoparticles:a novel therapeutic approach for the prevention and treatment of inflammatory bowel disease and colitis-associated cancer[J]. Biomaterials, 2016, 101:321-340.
[59] Zhang M, Xiao B, Wang H, et al. Edible ginger-derived nano-lipids loaded with doxorubicin as a novel drug-delivery approach for colon cancer therapy[J]. Mol Ther, 2016, 24(10):1783-1796.
[60] Zhang M, Collins JF, Merlin D. Do ginger-derived nanoparticles represent an attractive treatment strategy for inflammatory bowel diseases?[J]. Nanomedicine (Lond), 2016, 11(23):3035-3037.
[61] Zhang M, Xu C, Liu D, et al. Oral delivery of nanoparticles loaded with ginger active compound, 6-shogaol, attenuates Ulcerative Colitis and Promotes Wound Healing in a Murine Model of Ulcerative Colitis[J]. J Crohns Colitis, 2018, 12(2):217-229.
[62] Yun CS, Choi YG, Jeong MY, et al. Moutan cortex radicis inhibits inflammatory changes of gene expression in lipopolysaccharide-stimulated gingival fibroblasts[J]. J Nat Med, 2013, 67(3):576-589.
[63] Jamal J, Mustafa MR, Wong PF. Paeonol protects against premature senescence in endothelial cells by modulating Sirtuin 1 pathway[J]. J Ethnopharmacol, 2014, 154(2):428-436.
[64] Gong X, Yang Y, Huang L, et al. Antioxidation, anti-inflammation and anti-apoptosis by paeonol in LPS/d-GalN-induced acute liver failure in mice[J]. Int Immunopharmacol, 2017, 46:124-132.
[65] Fu PK, Yang CY, Huang SC, et al. Evaluation of LPS-induced acute lung injury attenuation in rats by aminothiazole-paeonol derivatives[J]. Molecules, 2017, 22(10):1605.
[66] Meng Y, Wang M, Xie X, et al. Paeonol ameliorates imiquimod-induced psoriasis-like skin lesions in BALB/c mice by inhibiting the maturation and activation of dendritic cells[J]. Int J Mol Med, 2017, 39(5):1101-1110.
[67] Zhang L, Tao L, Shi T, et al. Paeonol inhibits B16F10 melanoma metastasis in vitro and in vivo via disrupting proinflammatory cytokines-mediated NF-kappaB and STAT3 pathways[J]. IUBMB Life, 2015, 67(10):778-788.
[68] Li M, Tan SY, Wang XF. Paeonol exerts an anticancer effect on human colorectal cancer cells through inhibition of PGE(2) synthesis and COX-2 expression[J]. Oncol Rep, 2014, 32(6):2845-2853.
[69] Liu J, Wang S, Feng L, et al. Hypoglycemic and antioxidant activities of paeonol and its beneficial effect on diabetic encephalopathy in streptozotocin-induced diabetic rats[J]. J Med Food, 2013, 16(7):577-586.
[70] Jin X, Wang J, Xia ZM, et al. Anti-inflammatory and anti-oxidative activities of paeonol and its metabolites through blocking MAPK/ERK/p38 signaling pathway[J]. Inflammation, 2016, 39(1):434-446.
[71] Zong S, Pu Y, Li S, et al. Beneficial anti-inflammatory effect of paeonol self-microemulsion-loaded colon-specific capsules on experimental ulcerative colitis rats[J]. Artif Cells Nanomed Biotechnol, 2018, doi:10.1080/21691401.2017.1423497.
[72] Rtibi K, Grami D, Wannes D, et al. Ficus carica aqueous extract alleviates delayed gastric emptying and recovers ulcerative colitis-enhanced acute functional gastrointestinal disorders in rats[J]. J Ethnopharmacol, 2018, 224:242-249.
[73] Zhang H, Deng A, Zhang Z, et al. The protective effect of epicatechin on experimental ulcerative colitis in mice is mediated by increasing antioxidation and by the inhibition of NF-kappaB pathway[J]. Pharmacol Rep, 2016, 68(3):514-520.
[74] De Rezende AA, Graf U, Guterres Zda R, et al. Protective effects of proanthocyanidins of grape (Vitis vinifera L.) seeds on DNA damage induced by doxorubicin in somatic cells of drosophila melanogaster[J]. Food Chem Toxicol, 2009, 47(7):1466-1472.
[75] Wang YH, Yang XL, Wang L, et al. Effects of proanthocyanidins from grape seed on treatment of recurrent ulcerative colitis in rats[J]. Can J Physiol Pharmacol, 2010, 88(9):888-898.
[76] Li YH, Xiao HT, Hu DD, et al. Berberine ameliorates chronic relapsing dextran sulfate sodium-induced colitis in C57BL/6 mice by suppressing Th17 responses[J]. Pharmacol Res, 2016, 110:227-239.
[77] Zhang LC, Wang Y, Tong LC, et al. Berberine alleviates dextran sodium sulfate-induced colitis by improving intestinal barrier function and reducing inflammation and oxidative stress[J]. Exp Ther Med, 2017, 13(6):3374-3382.
[78] DiGuilio KM, Mercogliano CM, Born J, et al. Sieving characteristics of cytokine-and peroxide-induced epithelial barrier leak:inhibition by berberine[J]. World J Gastrointest Pathophysiol, 2016, 7(2):223-234.
[79] Li YH, Zhang M, Xiao HT, et al. Addition of berberine to 5-aminosalicylic acid for treatment of dextran sulfate sodium-induced chronic colitis in C57BL/6 mice[J]. PLoS One, 2015, 10(12):e0144101.
[80] Li YH, Zhang M, Fu HB, et al. Pre-clinical toxicity of a combination of berberine and 5-aminosalicylic acid in mice[J]. Food Chem Toxicol, 2016, 97:150-158.
[81] Zhong Z, Xiong Y, Yang L. Effect of matrine on the expression of cytokines and free radicals of intestinal mucosa in rats with TNBS-induced ulcerative colitis[J]. Chin Med Biotechnol, 2011, 6(4):251-254.
[82] Tang Q, Fan H, Shou Z, et al. Study on protective mechanism of kushenin injection on colonic mucosa of experimental colitis rats[J]. China J Chin Mater Med, 2012, 37(12):1814-1817.
[83] Fan H, Liao Y, Tang Q, et al. Role of beta2-adrenoceptor-beta-arrestin2-nuclear factor-kappaB signal transduction pathway and intervention effects of oxymatrine in ulcerative colitis[J]. Chin J Integr Med, 2012, 18(7):514-521.
[84] Zhou PQ, Fan H, Hu H, et al. Role of DOR-beta-arrestin1-Bcl2 signal transduction pathway and intervention effects of oxymatrine in ulcerative colitis[J]. J Huazhong Univ Sci Technolog Med Sci, 2014, 34(6):815-820.
[85] Chen Q, Duan X, Fan H, et al. Oxymatrine protects against DSS-induced colitis via inhibiting the PI3K/AKT signaling pathway[J]. Int Immunopharmacol, 2017, 53:149-157.
[86] Liu Q, Zhang YJ, Yang CR, et al. Phenolic antioxidants from green tea produced from Camellia crassicolumna Var. multiplex[J]. J Agric Food Chem, 2009, 57(2):586-590.
[87] Pal R, Chaudhary MJ, Tiwari PC, et al. Protective role of theophylline and their interaction with nitric oxide (NO) in adjuvant-induced rheumatoid arthritis in rats[J]. Int Immunopharmacol, 2015, 29(2):854-862.
[88] Lal D, Manocha S, Ray A, et al. Comparative study of the efficacy and safety of theophylline and doxofylline in patients with bronchial asthma and chronic obstructive pulmonary disease[J]. J Basic Clin Physiol Pharmacol, 2015, 26(5):443-451.
[89] Urbanova A, Kertys M, Simekova M, et al. Bronchodilator and anti-inflammatory action of theophylline in a model of ovalbumin-induced allergic inflammation[J]. Adv Exp Med Biol, 2016, 935:53-62.
[90] Barnes PJ. Theophylline:new perspectives for an old drug[J]. Am J Respir Crit Care Med, 2003, 167(6):813-818.
[91] Ghasemi-Pirbaluti M, Motaghi E, Najafi A, et al. The effect of theophylline on acetic acid induced ulcerative colitis in rats[J]. Biomed Pharmacother, 2017, 90:153-159.
[92] Liu X, He H, Huang T, et al. Tanshinone ⅡA protects against dextran sulfate sodium-(DSS-) induced colitis in mice by modulation of neutrophil infiltration and activation[J]. Oxid Med Cell Longev, 2016, 2016:7916763.
[93] Zhang X, Wang Y, Ma Z, et al. Tanshinone ⅡA ameliorates dextran sulfate sodium-induced inflammatory bowel disease via the pregnane X receptor[J]. Drug Des Devel Ther, 2015, 9:6343-6362.
[94] Andujar I, Rios JL, Giner RM, et al. Beneficial effect of shikonin on experimental colitis induced by dextran sulfate sodium in BALB/c mice[J]. Evid Based Complement Alternat Med, 2012, 2012:271606.
[95] Andujar I, Marti-Rodrigo A, Giner RM, et al. Shikonin prevents early phase inflammation associated with azoxymethane/dextran sulfate sodium-induced colon cancer and induces apoptosis in human colon cancer cells[J]. Planta Med, 2018, 84(9-10):674-683.
[96] Andujar I, Rios JL, Giner RM, et al. Shikonin promotes intestinal wound healing in vitro via induction of TGF-beta release in IEC-18 cells[J]. Eur J Pharm Sci, 2013, 49(4):637-641.
[97] Wu WJ, Yan R, Li T, et al. Pharmacokinetic alterations of rhubarb anthraquinones in experimental colitis induced by dextran sulfate sodium in the rat[J]. J Ethnopharmacol, 2017, 198:600-607.
[98] Ge H, Tang H, Liang Y, et al. Rhein attenuates inflammation through inhibition of NF-kappaB and NALP3 inflammasome in vivo and in vitro[J]. Drug Des Devel Ther, 2017, 11:1663-1671.
[99] Luo S, Deng X, Liu Q, et al. Emodin ameliorates ulcerative colitis by the flagellin-TLR5 dependent pathway in mice[J]. Int Immunopharmacol, 2018, 59:269-275.
[100] Kim SJ, Kim MC, Lee BJ, et al. Anti-inflammatory activity of chrysophanol through the suppression of NF-kappaB/caspase-1 activation in vitro and in vivo[J]. Molecules, 2010, 15(9):6436-6451.
[101] Qiao X, Ye M, Pan DL, et al. Differentiation of various traditional Chinese medicines derived from animal bile and gallstone:simultaneous determination of bile acids by liquid chromatography coupled with triple quadrupole mass spectrometry[J]. J Chromatogr A, 2011, 1218(1):107-117.
[102] Arumugam S, Sreedhar R, Thandavarayan RA, et al. Telmisartan treatment targets inflammatory cytokines to suppress the pathogenesis of acute colitis induced by dextran sulphate sodium[J]. Cytokine, 2015, 74(2):305-312.
[103] Yang Y, He J, Suo Y, et al. Anti-inflammatory effect of taurocholate on TNBS-induced ulcerative colitis in mice[J]. Biomed Pharmacother, 2016, 81:424-430.
[104] Cao SS, Zimmermann EM, Chuang BM, et al. The unfolded protein response and chemical chaperones reduce protein misfolding and colitis in mice[J]. Gastroenterology, 2013, 144(5):989-1000.
[105] Berger E, Haller D. Structure-function analysis of the tertiary bile acid TUDCA for the resolution of endoplasmic reticulum stress in intestinal epithelial cells[J]. Biochem Biophys Res Commun, 2011, 409(4):610-615.
[106] Yang Y, He J, Suo Y, et al. Tauroursodeoxycholate improves 2, 4, 6-trinitrobenzenesulfonic acid-induced experimental acute ulcerative colitis in mice[J]. Int Immunopharmacol, 2016, 36:271-276.
[107] Fan H, Liu XX, Zhang LJ, et al. Intervention effects of QRZSLXF, a Chinese medicinal herb recipe, on the DOR-beta-arrestin1-Bcl2 signal transduction pathway in a rat model of ulcerative colitis[J]. J Ethnopharmacol, 2014, 154(1):88-97.
[108] Sugimoto S, Naganuma M, Kanai T. Indole compounds may be promising medicines for ulcerative colitis[J]. J Gastroenterol, 2016, 51(9):853-861.
[109] Gao W, Guo Y, Wang C, et al. Indirubin ameliorates dextran sulfate sodium-induced ulcerative colitis in mice through the inhibition of inflammation and the induction of Foxp3-expressing regulatory T cells[J]. Acta Histochem, 2016, 118(6):606-614.
[110] Gao W, Zhang L, Wang X, et al. The combination of indirubin and isatin attenuates dextran sodium sulfate-induced ulcerative colitis in mice[J]. Biochem Cell Biol, 2018, 96(5):636-645.
[111] Socca EA, Luiz-Ferreira A, de Faria FM, et al. Inhibition of tumor necrosis factor-alpha and cyclooxigenase-2 by Isatin:a molecular mechanism of protection against TNBS-induced colitis in rats[J]. Chem Biol Interact, 2014, 209:48-55.
[112] NoorShahida A, Wong TW, Choo CY. Hypoglycemic effect of quassinoids from Brucea javanica (L.) Merr (Simaroubaceae) seeds[J]. J Ethnopharmacol, 2009, 124(3):586-591.
[113] Zhang L, Feng X, Ma D, et al. Brusatol isolated from Brucea javanica (L.) Merr. induces apoptotic death of insect cell lines[J]. Pestic Biochem Physiol, 2013, 107(1):18-24.
[114] Turpaev K, Welsh N. Brusatol inhibits the response of cultured beta-cells to pro-inflammatory cytokines in vitro[J]. Biochem Biophys Res Commun, 2015, 460(3):868-872.
[115] Tang W, Xie J, Xu S, et al. Novel nitric oxide-releasing derivatives of brusatol as anti-inflammatory agents:design, synthesis, biological evaluation, and nitric oxide release studies[J]. J Med Chem, 2014, 57(18):7600-7612.
[116] Zhou J, Tan L, Xie J, et al. Characterization of brusatol self-microemulsifying drug delivery system and its therapeutic effect against dextran sodium sulfate-induced ulcerative colitis in mice[J]. Drug Deliv, 2017, 24(1):1667-1679.
[117] Pandurangan AK, Ismail S, Saadatdoust Z, et al. Allicin alleviates dextran sodium sulfate-(DSS-) induced ulcerative colitis in BALB/c mice[J]. Oxid Med Cell Longev, 2015, 2015:605208.
[118] Yao J, Wang JY, Liu L, et al. Anti-oxidant effects of resveratrol on mice with DSS-induced ulcerative colitis[J]. Arch Med Res, 2010, 41(4):288-294.
[119] Trapp V, Parmakhtiar B, Papazian V, et al. Anti-angiogenic effects of resveratrol mediated by decreased VEGF and increased TSP1 expression in melanoma-endothelial cell co-culture[J]. Angiogenesis, 2010, 13(4):305-315.
[120] Singh UP, Singh NP, Singh B, et al. Role of resveratrol-induced CD11b+ Gr-1+ myeloid derived suppressor cells (MDSCs) in the reduction of CXCR3+ T cells and amelioration of chronic colitis in IL-10-/- mice[J]. Brain Behav Immun, 2012, 26(1):72-82.
[121] Abdallah DM, Ismael NR. Resveratrol abrogates adhesion molecules and protects against TNBS-induced ulcerative colitis in rats[J]. Can J Physiol Pharmacol, 2011, 89(11):811-818.
[122] Yao J, Wei C, Wang JY, et al. Effect of resveratrol on Treg/Th17 signaling and ulcerative colitis treatment in mice[J]. World J Gastroenterol, 2015, 21(21):6572-6581.
[123] Wang Z, Jin H, Xu R, et al. Triptolide downregulates Rac1 and the JAK/STAT3 pathway and inhibits colitis-related colon cancer progression[J]. Exp Mol Med, 2009, 41(10):717-727.
[124] Li CP, Li JH, He SY, et al. Effect of curcumin on p38MAPK expression in DSS-induced murine ulcerative colitis[J]. Genet Mol Res, 2015, 14(2):3450-3458.
[125] Ghasemi-Pirbaluti M, Motaghi E, Najafi A, et al. The effect of theophylline on acetic acid induced ulcerative colitis in rats[J]. Biomed Pharmacother, 2017, 90:153-159.
[126] Zhu SM, Hao WW, Tang ZP, et al. Effect of indirubin on cytokinesin colonic mucosa of DSS-induced colitisin mice[J]. Chin J Integr West Med Dig, 2011, 19(6):370-372.
[127] Yu FY, Huang SG, Zhang HY, et al. Effect of baicalin on signal transduction and activating transcription factor expression in ulcerative colitis patients[J]. Chin J Integr Tradit Chin West, 2015, 35(4):419-424.
[128] Shin HS, Satsu H, Bae MJ, et al. Catechol groups enable reactive oxygen species scavenging-mediated suppression of PKD-NFkappaB-IL-8 signaling pathway by chlorogenic and caffeic acids in human intestinal cells[J]. Nutrients, 2017, 9(2):165.
[129] Palócz O, Pászti-Gere E, Gálfi P, et al. Chlorogenic acid combined with Lactobacillus plantarum 2142 reduced LPS-induced intestinal inflammation and oxidative stress in IPEC-J2 Cells[J]. PLoS ONE, 2016, 11(11):e0166642.
[130] Bai A, Lu N, Guo Y, et al. Tanshinone ⅡA ameliorates trinitrobenzene sulfonic acid (TNBS)-induced murine colitis[J]. Dig Dis Sci, 2008, 53(2):421-428.

Related Articles:
1. DING Pei-Lan, HE Chang-Ming, CHENG Zhi-Hong, CHEN Dao-Feng.Flavonoids rather than alkaloids as the diagnostic constituents to distinguish Sophorae Flavescentis Radix from Sophorae Tonkinensis Radix et Rhizoma: an HPLC fingerprint study[J]. Chinese Journal of Natural Medicines, 2018,16(12): 951-960